Abstract
Pluronic F127 (PF-127) shows thermoreversible property, which is of the utmost interest in optimizing drug formulation and delivery. However, its hitherto unresolved drawback of a low phase transition temperature (T tr) has limited its application in injectable drug delivery systems. We have recently synthesized a new type of PF-127 copolymers with higher T tr using a simple oxidative method. Here, we have investigated the drug-releasing feature of oxidized PF-127 and oxidized PF-127-containing silver nanoparticles (SNPs), carrying arsenic trioxide (ATO), in a subcutaneous model of rats. Injectable hydrogels prepared with oxidized PF-127s were less viscous and easier to inject, at the same concentration, than their precursor. Addition of SNPs further elevated T tr, resulting in even lower viscosity of the injectable hydrogel prepared from SNP-containing oxidized PF-127. The oxidized PF-127 copolymers did not differ significantly in ATO-releasing ability, compared with parental PF-127, but the addition of SNPs altered the ATO-releasing feature of oxidized PF-127 to some extent. ATO-carrying oxidized PF-127s had similar toxicity, but the addition of SNPs enhanced the hepatotoxicity of ATO, as evidenced by elevated serum levels of alanine aminotransferase and aspartate aminotransferase and histological alterations, compared to parental PF-127. The results presented herein warrant further investigation of the modified PF-127 copolymers to deliver ATO or other drugs in the form of injectable hydrogels.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Ruel-Gariépy E, Leroux JC. In situ-forming hydrogels - review of temperature-sensitive systems. Eur J Pharm Biopharm. 2004;58:409–26.
Escobar-Chavez JJ, Lopez-Cervantes M, Naik A, Kalia YN, Quintanar-Guerrero D, Ganem-Quintanar A. Applications of therm-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharmaceut Sci. 2006;9:339–58.
Schmolka IR. Artificial skin. I. Preparation and properties of pluronic F-127 gels for treatment of burns. J Biomed Mater Res. 1972;6:571–82.
Zhang C, Easteal AJ. Milder changes in chemistry make a significant difference in phase transition temperatures for triblock copolymers on PEO106-PPO70-PEO106 block copolymer chains. Macromol Chem Phys. 2008;209:1220–31.
Armstrong JK, Parsonage J, Chowdhry B, Leharne S, Mitchell J, Beezer A, et al. Scanning densitometric and calorimetric studies of poly(ethylene oxide)/poly(propylene oxide)/poly(ethylene oxide) triblock copolymers (poloxamers) in dilute aqueous solution. J Phys Chem. 1993;97:3904–9.
Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23:2709–28.
Shim WS, Yoo JS, Bae YH, Lee DS. Novel injectable pH and temperature sensitive block copolymer hydrogel. Biomacromolecules. 2005;6:2930–4.
Soignet SL. Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia. Oncologist. 2001;6:11–6.
Litzow MR. Arsenic trioxide. Expert Opin Pharmacother. 2008;9:1773–85.
Leu L, Mohassel L. Arsenic trioxide as first-line treatment for acute promyelocytic leukemia. Am J Health Syst Pharm. 2009;66:1913–8.
Banerjee P, Bhattacharyya SS, Bhattacharjee N, Pathak S, Boujedaini N, Belon P, et al. Ascorbic acid combats arsenic-induced oxidative stress in mice liver. Ecotoxicol Environ Saf. 2009;72:639–49.
Allen T, Rana SV. Effect of n-propylthiouracil or thyroxine on arsenic trioxide toxicity in the liver of rat. J Trace Elem Med Biol. 2007;21:194–203.
Mahmood M, Casciano DA, Mocan T, Iancu C, Xu Y, Mocan L, et al. Cytotoxicity and biological effects of functional nanomaterials delivered to various cell lines. J Appl Toxicol. 2010;30:74–83.
Edwards-Jones V. The benefits of silver in hygiene, personal care and healthcare. Lett Appl Microbiol. 2009;49:147–52.
Liu B, Pan S, Dong X, Qiao H, Jiang H, Krissansen GW, et al. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer Sci. 2006;97:675–81.
Zhao S, Zhang X, Zhang J, Zhang JH, Zou H, Liu Y, et al. Intravenous administration of arsenic trioxide encapsulated in liposomes inhibits C6 gliomas in rat brains. J Chemother. 2008;20:253–62.
Adaira BM, Hudgensb EE, Schmittb MT, Calderonb RL, Thomasa DJ. Total arsenic concentrations in toenails quantified by two techniques provide a useful biomarker of chronic arsenic exposure in drinking water. Environ Res. 2006;101:213–20.
Jiang H, Meng F, Li W, Tong L, Qiao H, Sun X. Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery. 2007;141:32–40.
Jihen elH, Imed M, Fatima H, Abdelhamid K. Protective effects of selenium (Se) and zinc (Zn) on cadmium (Cd) toxicity in the liver and kidney of the rat: histology and Cd accumulation. Food Chem Toxicol. 2008;46:3522–7.
Jamshidzadeh A, Baghban M, Azarpira N. Effects of tomato extract on oxidative stress induced toxicity in different organs of rats. Food Chem Toxicol. 2008;46:3612–5.
Yavuz Y, Yurumez Y, Ciftci IH. Effect of diphenhydramine on myocardial injury caused by organophosphate poisoning. Clin Toxicol. 2008;46:67–70.
Ni J, Chen G, Shen Z, Li X, Liu H, Huang Y, et al. Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia. Chin Med J. 1998;111:1107–10.
Fox E, Razzouk BI, Widemann BC, Xiao S, O’Brien M, Goodspeed W, et al. Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma. Blood. 2008;111:566–73.
Liu Y, Lu WL, Wang JC, Zhang X, Zhang H, Wang XQ, et al. Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization. J Control Release. 2007;117:387–95.
Veyries ML, Couarraze G, Geiger S, Agnely F, Massias L, Kunzli B, et al. Controlled release of vancomycin from poloxamer 407 gels. Int J Pharm. 1999;192:183–93.
Amiji MM, Lai PK, Shenoy DB, Rao M. Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation. Pharm Dev Technol. 2002;7:195–202.
Tang J, Xiong L, Wang S, Wang J, Liu L, Li J, et al. Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol. 2009;9:4924–32.
Choi JE, Kim S, Ahn JH, Youn P, Kang JS, Park K, et al. Induction of oxidative stress and apoptosis by silver nanoparticles in the liver of adult zebrafish. Aquat Toxicol. 2010;100:151–9.
Alakhov V, Klinski E, Li S, Pietrzynski G, Venne A, Batrakova E, et al. Block copolymer based formulation of doxorubicin. From cell screen to clinical trials. Colloids Surf B Biointerfaces. 1999;16:113–34.
ACKNOWLEDGMENTS
The work was partly supported by the National Natural Scientific Foundation of China (30872987, 30973474, and 81100305) and the Foundation for Research, Science and Technology of New Zealand (3606727).
Conflict of Interest
The authors report no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
M.Y. and Z.C. contributed equally to this work.
Rights and permissions
About this article
Cite this article
Ma, Y., Zhang, C., Chen, X. et al. The Influence of Modified Pluronic F127 Copolymers with Higher Phase Transition Temperature on Arsenic Trioxide-Releasing Properties and Toxicity in a Subcutaneous Model of Rats. AAPS PharmSciTech 13, 441–447 (2012). https://doi.org/10.1208/s12249-012-9756-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-012-9756-9